HeartSciences (HSCS) Net Equity Issued and Repurchased (2022 - 2025)
HeartSciences' (HSCS) quarterly Net Equity Issued and Repurchased came in at $171276.0 in Q2 2025, down 53.58% on a QoQ basis from $369000.0 in Q3 2024.
HeartSciences (HSCS) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $171276.0 in Q2 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $171276.0 in Q2 2025, while the trailing twelve-month figure through Apr 2026 was $801276.0 (down 49.96% YoY) and the FY2026 annual result came in at $172839.0, down 84.94% from the prior year.
- Net Equity Issued and Repurchased fell to $171276.0 in Q2 2025, from $369000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $5.2 million in Q3 2022 to a low of $171276.0 in Q2 2025.
- A 4-year average of $1.4 million and a median of $630000.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2023 — Net Equity Issued and Repurchased tumbled 84.6% — and 2024, when it plunged 53.88%.
- Tracing HSCS's Net Equity Issued and Repurchased over 4 years: stood at $5.2 million in 2022, then tumbled by 87.87% to $630000.0 in 2023, then slumped by 41.43% to $369000.0 in 2024, then tumbled by 53.58% to $171276.0 in 2025.
- The last three Net Equity Issued and Repurchased figures came in at $171276.0 (Q2 2025), $369000.0 (Q3 2024), and $630000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | HeartSciences | 6.45 Mn | 4.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 171,276.00 |
| Apr 30, 2025 | 171,276.00 |
| Jul 31, 2024 | 369,000.00 |
| Jul 31, 2024 | 369,000.00 |
| Oct 31, 2023 | 630,000.00 |
| Oct 31, 2023 | 630,000.00 |
| Jul 31, 2023 | 800,000.00 |
| Jul 31, 2023 | 800,000.00 |
| Jul 31, 2022 | 5.19 Mn |
| Jul 31, 2022 | 5.19 Mn |